Recently, researchers found that the expression of FOXM1 was positive correlated with FOXP3 (the specific molecular marker of Tregs) and FOXM1 may induce immune suppression via recruiting FOXP3 positive Tregs in cancer therapy [65]. Here, FOXP3 is linked to cancer.